'VEEP' in children with Hodgkin's disease--a regimen to decrease late sequelae.

In an attempt to decrease the risk of second malignancies and future infertility in children with Hodgkin's disease (HD) while retaining acceptable remission rates, an anthracycline based regimen containing no alkylating agent has been devised. VEEP contains vincristine, epirubicin, etoposide a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: O'Brien, M. E., Pinkerton, C. R., Kingston, J., Mott, M., Tait, D., Meller, S., Radford, M., Malpas, J., McElwain, T. J.
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 1992
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1977393/
https://ncbi.nlm.nih.gov/pubmed/1586603
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares